» Articles » PMID: 35209134

Mitochondrial ROS-Mediated Metabolic and Cytotoxic Effects of Isoproterenol on Cardiomyocytes Are P53-Dependent and Reversed by Curcumin

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2022 Feb 25
PMID 35209134
Authors
Affiliations
Soon will be listed here.
Abstract

Acute β-adrenergic stimulation contributes to heart failure. Here, we investigated the role of p53 in isoproterenol (ISO)-mediated metabolic and oxidative stress effects on cardiomyocytes and explored the direct protective effects offered by the antioxidant nutraceutical curcumin. Differentiated H9C2 rat cardiomyocytes treated with ISO were assayed for glucose uptake, lactate release, and mitochondrial reactive oxygen species (ROS) generation. Survival was assessed by sulforhodamine B assays. Cardiomyocytes showed significantly decreased glucose uptake and lactate release, as well as increased cellular toxicity by ISO treatment. This was accompanied by marked dose-dependent increases of mitochondria-derived ROS. Scavenging with N-acetyl-L-cysteine (NAC) effectively lowered ROS levels, which completely recovered glycolytic metabolism and survival suppressed by ISO. Mechanistically, ISO reduced extracellular-signal-regulated kinase (ERK) activation, whereas it upregulated p53 expression in an ROS-dependent manner. Silencing of p53 with siRNA blocked the ability of ISO to stimulate mitochondrial ROS and suppress glucose uptake, and partially recovered cell survival. Finally, curcumin completely reversed the metabolic and ROS-stimulating effects of ISO. Furthermore, curcumin improved survival of cardiomyocytes exposed to ISO. Thus, ISO suppresses cardiomyocyte glycolytic metabolism and survival by stimulating mitochondrial ROS in a p53-dependent manner. Furthermore, curcumin can efficiently rescue cardiomyocytes from these adverse effects.

Citing Articles

Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies.

Adu-Amankwaah J, You Q, Liu X, Jiang J, Yang D, Liu K MedComm (2020). 2025; 6(3):e70134.

PMID: 40066229 PMC: 11892029. DOI: 10.1002/mco2.70134.


CTRP6-mediated cardiac protection in heart failure via the AMPK/SIRT1/PGC-1α signalling pathway.

Fan T, Zhu N, Li M, Wang Z, Lin X Exp Physiol. 2024; 109(12):2031-2045.

PMID: 39325807 PMC: 11607624. DOI: 10.1113/EP092036.


Molecular mechanism and potential role of mitophagy in acute pancreatitis.

Zhu L, Xu Y, Lei J Mol Med. 2024; 30(1):136.

PMID: 39227768 PMC: 11373529. DOI: 10.1186/s10020-024-00903-x.


Triiodo-L-thyronine (T3) downregulates Npr1 gene (coding for natriuretic peptide receptor-A) transcription in H9c2 cells: involvement of β-AR-ROS signaling.

Nagaraj G, Vellaichamy E Endocrine. 2024; 85(3):1075-1090.

PMID: 38713329 DOI: 10.1007/s12020-024-03849-6.


Modeling cardiomyocyte signaling and metabolism predicts genotype-to-phenotype mechanisms in hypertrophic cardiomyopathy.

Khalilimeybodi A, Saucerman J, Rangamani P Comput Biol Med. 2024; 175:108499.

PMID: 38677172 PMC: 11175993. DOI: 10.1016/j.compbiomed.2024.108499.


References
1.
Matoba S, Kang J, Patino W, Wragg A, Boehm M, Gavrilova O . p53 regulates mitochondrial respiration. Science. 2006; 312(5780):1650-3. DOI: 10.1126/science.1126863. View

2.
Jung K, Lee J, Quach C, Paik J, Oh H, Park J . Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation. J Nucl Med. 2013; 54(12):2161-7. DOI: 10.2967/jnumed.112.115436. View

3.
Gomes A, Ramos H, Soares J, Saraiva L . p53 and glucose metabolism: an orchestra to be directed in cancer therapy. Pharmacol Res. 2018; 131:75-86. DOI: 10.1016/j.phrs.2018.03.015. View

4.
Itoh K, Minakawa M, Ono Y, Tsushima T, Fukui K, Fukuda I . Role of oxidative stress in hypertrophied myoblasts stimulated by isoproterenol. Gen Thorac Cardiovasc Surg. 2008; 56(4):170-6. DOI: 10.1007/s11748-007-0214-7. View

5.
Neubauer S . The failing heart--an engine out of fuel. N Engl J Med. 2007; 356(11):1140-51. DOI: 10.1056/NEJMra063052. View